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a b s t r a c t
Knee osteoarthritis (OA) is a degenerative joint condition and a leading cause of physical disability in the
United States. Quadriceps weakness and inﬂammatory cytokines contribute to the pathogenesis of knee
OA, and both of which, increase with vitamin D deﬁciency. Other micronutrients, such as vitamins C and E
and β-carotene, modulate inﬂammatory cytokines and decrease during inﬂammation. The purpose of this
study was to test the hypothesis that vitamin D deﬁciency associates with quadriceps weakness, an
increase in serum cytokines, and a decrease in circulating micronutrients in subjects with knee OA.
Subjects (age, 4871 y; serum 25(OH)D, 25.871.1 ng/mL) with knee OA were categorized as vitamin D
deﬁcient (n¼17; serum 25(OH)Dr20 ng/mL), insufﬁcient (n¼21; serum 25(OH)D 20–29 ng/mL), or
sufﬁcient (n¼18; serum 25(OH)DZ30 ng/mL). Single-leg strength (concentric knee extension–ﬂexion
contraction cycles at 60 1/s) and blood cytokine, carotene (α and β), ascorbic acid, and tocopherol (α and γ)
concentrations were measured. Quadriceps peak torque, average power, total work, and deceleration were
signiﬁcantly (all po0.05) impaired with vitamin D deﬁciency. Serum γ-tocopherol concentrations were
signiﬁcantly (po0.05) increased with vitamin D deﬁciency. In the vitamin D sufﬁcient group, γ-tocopherol
inversely correlated (r¼0.47, po0.05) with TNF-α, suggesting a pro-inﬂammatory increase with
a γ-tocopherol decrease despite a sufﬁcient serum 25(OH)D concentration. We conclude that vitamin D
deﬁciency is detrimental to quadriceps function, and in subjects with vitamin D sufﬁciency, γ-tocopherol
could have an important anti-inﬂammatory role in a pathophysiological condition mediated by
inﬂammation.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
Knee osteoarthritis (OA) is a degenerative joint condition and a
leading cause of physical disability in the United States, especially
with advancing age. With the aging population growing, there is
an increasing demand to improve the quality life and daily
function in people suffering with knee OA. A compelling body of
literature is revealing an increase in cartilage loss and knee OA
with vitamin D deﬁciency (i.e., serum 25-hydroxyvitamin D (25
(OH)D)o20 ng/mL) [1,2]. This is an area of uncertainty, however,
as conﬂicting reports suggest that vitamin D deﬁciency does not
associate with knee OA [3–7]. Despite this ambiguity, vitamin D is
an attractive therapeutic alternative because it modulates the
mechanical (i.e., quadriceps weakness) [8] and biochemical (i.e.,
inﬂammatory cytokines) [9] factors believed to contribute to the
pathogenesis of knee OA.
Quadricep weakness is an early symptom of OA that precedes
and mediates cartilage loss by minimizing the shock absorption
across the knee joint [10,11]. In vitamin D deﬁcient elderly,
physical function is impaired and quadriceps weakness is apparent
[12–17]. The culprit(s) contributing to these impairments are
unknown in humans, but evidence suggests that decrements in
phosphate metabolism, calcium handling and transport, or cyto-
skeletal protein expression could be the underlying mechanisms
mediating muscular weakness with low vitamin D [18,19]. The
inﬂuence of vitamin D on skeletal muscle function is illustrated
further by reports demonstrating that supplemental vitamin D
(i.e., with 25(OH)D or ergocalciferol) attenuates the age-related
decrease or improves lower extremity function and muscle
strength in elderly [20,21]. In contrast, the impact of vitamin D
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on physical function or muscle strength in elderly is questioned as
conﬂicting reports exist [22,23]. Consistent with data suggesting
that vitamin D is not inﬂuential on physical function in elderly,
results in subjects with knee OA imply that an increase in serum
25(OH)D does not attenuate the decline in physical function [5,24].
However, it is unknown if vitamin D deﬁciency associates with
quadriceps weakness in subjects with knee OA.
Although caution is recommended in its interpretation as
an exclusive indicator of knee OA [25], an increase in serum C-
reactive protein (CRP) is apparent in subjects with knee OA [26].
Additionally, serum CRP and inﬂammatory cytokines (e.g., inter-
leukin (IL)-6) predict cartilage loss [27,28] and knee OA [29]. These
systemic ﬁndings reﬂect the local production of pro-inﬂammatory
cytokines, such as tumor necrosis factor (TNF)-α and IL-1β, that
induce cartilage catabolism and knee OA [30,31]. In isolated
immune cells, vitamin D (1,25-dihydroxyvitamin D or increase in
serum 25(OH)D) decreases pro-inﬂammatory cytokine production
[32,33]. The cytokine-modulating property of vitamin D is related
to its interaction with the cell surface or nuclear vitamin D
receptors (VDR). The nuclear VDR heterodimerizes with the
retinoic X receptor (RXR) upon vitamin D (1,25-dihyroxyvitamin D)
binding, forming a complex that attaches to a vitamin D response
element that regulates cytokine gene expression see [34] for review.
In addition to the VDR–RXR complex, vitamin D regulates cytokine
expression by modulating the expression and activity of nuclear
factor-κB (NF-κB) and nuclear factor of activated T cells see [34] for
review. Upon binding to the cell surface receptor, vitamin D induces
rapid and non-genomic cytokine responses through mitogen-
activated protein kinase, protein kinase C, cGMP, and phosphoinosi-
tide metabolism signaling pathways, [35]. Consistent with its
cytokine-modulating inﬂuence in isolated cell studies, low serum
25(OH)D concentrations associate with an increase in pro-
inﬂammatory cytokines across a range of physiological and patho-
physiological conditions in humans [36–39]. There is, however,
paucity in the data regarding the inﬂuence of vitamin D deﬁciency
on inﬂammatory cytokines is subjects with knee OA.
It is also unknown if vitamin D deﬁciency is accompanied by a
decrease in other micronutrients that modulate inﬂammatory cyto-
kines. Vitamins C and E (α- or γ-tocopherol alone or in combination)
are potent dietary antioxidants that decrease cytokine (such as IL-6
and TNF-α) levels in the blood [40] and inhibit cytokine production
from isolated immune cells [41–45]. Conversely, β-carotene increases
circulating TNF-α concentrations [46] and production from monocytes
[47,48]. In addition to their cytokine modulating property, an emer-
ging hypothesis is that inﬂammation confounds the interpretation of
circulating micronutrient levels [49,50]. Support of this hypothesis is
provided by data suggesting vitamin E and β-carotene decrease in the
circulation after a hip fracture and during inﬂammation [51]. Reports
from our lab [52–54] and others [55,56] also suggest a circulating
decrease in vitamins C (ascorbic acid) and D (25(OH)D) during the
acute inﬂammatory phase following minor and major orthopedic
surgery in humans.
Analyzing quadricep strength and inﬂammatory cytokines in
subjects with knee OA and with contrasting serum 25(OH)D
concentrations could identify the role of vitamin D status on
mechanical and biochemical mediators of this degenerative joint
condition. Inﬂammation contributes to this degenerative joint, and
if inﬂammation decreases micronutrients in the blood, it is
foreseeable that vitamins C and E and carotenoids decrease with
vitamin D deﬁciency. Thus, the purpose of this study was to
identify quadricep strength, inﬂammatory cytokines, and micro-
nutrients in subjects with knee OA and with contrasting serum 25
(OH)D concentrations. We hypothesized that vitamin D deﬁciency
associates with quadriceps weakness, an increase in serum cyto-
kine, and a decrease in circulating micronutrient in subjects with
knee OA.
Material and methods
To address the proposed hypothesis, potential subjects who
were modestly active (i.e., minimum level of 30 min of continuous
activity at least 3 times per week) were recruited from the practice
of orthopedic surgeons (RHT, GLR, and NGM) at The Orthopedic
Specialty Hospital (Murray, UT USA). Subjects were initially
screened for unilateral knee symptoms of knee OA, such as self-
reported knee pain and muscular (i.e., quadriceps or hamstring)
weakness. During screening, subjects were excluded from partici-
pation if: they were taking a daily dietary supplement during the
previous year, currently using anti-inﬂammatory medications or
other prescribed or recommended medications, suffered a lower
leg injury during the previous year that required the use of
crutches, tobacco use, or under physician guided treatment for
known disease. We limited our study population to 60 years of age
or younger as the association between serum 25(OH)D concentra-
tions and knee OA is apparent in this demographic [2]. Subjects
were informed of and provided written and verbal consent to the
experimental protocol and procedures. The Urban Central Region
Institutional Review Board at Intermountain Healthcare (Salt Lake
City, UT USA) approved this study. Data was collected between
December 2011 and October 2012 in Murray, UT (latitude 40 1N).
Study protocol
Following screening and enrollment, each subject reported to
the Physiology Research Laboratory at The Orthopedic Specialty
Hospital. At this visit, we obtained fasting blood samples and
administered the pain (0–20; 0, no pain; 20, extreme pain) and
physical function (0–68; 0, no physical impairment; 68, extreme
physical impairment) subsections of the Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) question-
naire [57]. We also completed single-leg strength testing and X-ray
imaging. Subjects were excluded from analysis if: (1) the WOMAC
pain score waso2 on any of the ﬁve questions in its subsection,
(2) there was no muscular weakness (i.e., deﬁcit in peak isokinetic
knee-extension or ﬂexion strength) in the symptomatic leg, or (3)
a Kellgren‐Lawrence gradeo2 was scored in the symptomatic
knee (Fig. 1). Subjects were instructed to refrain from using non-
steroidal anti-inﬂammatory drugs (NSAIDs), including aspirin,
ibuprofen, and naproxen sodium, at least 3 days prior to data
collection.
Single-leg strength testing
Peak isokinetic strength was performed unilaterally on a
Biodex S4 (Shirley, NY USA). Testing was performed on the leg
with reportedly no symptoms of OA ﬁrst. The rationale for
performing the non-symptomatic knee ﬁrst was to allow subjects
to experience the testing protocol on a healthy knee prior to
testing the symptomatic knee. Several practice repetitions were
performed on each leg prior to testing for warm-up and to become
familiar with the testing protocol and procedure. Once comforta-
ble with the testing protocol and procedure, each subject per-
formed 6 concentric knee extension–ﬂexion contractions at 601
per second through a full range of motion (901 of knee ﬂexion to
full extension). Subjects were instructed and verbally encouraged
to perform each contraction with maximal effort during the
isokinetic testing.
Radiography
X-ray images were taken of each knee in the anterior-posterior
view at 451 of knee ﬂexion. Radiographs of the knee joint space
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narrowing (mm) between the symptomatic and non-symptomatic
knee were viewed and analyzed using ImageJ software from the
National Institutes of Health. Severity of knee OA was classiﬁed
according to the scoring criteria established by Kellgren and
Lawrence [58]. The Kellgren–Lawrence [58] grading was as the
following: 0, no osteophytes or joint-space narrowing; 1, ques-
tionable osteophyte indicating possible OA; 2, deﬁnite osteophyte,
no joint-narrowing indicating mild OA; 3, r50% joint-space
narrowing indicating moderate OA; and 4, 450% joint-space
narrowing indicating severe OA.
Analytical blood chemistry procedures
Circulating vitamins
Serum 25(OH)D concentrations (ng/mL) were determined
using a chemiluminescent immunoassay (ARUP Laboratories, Salt
Lake City, UT USA). Patients were classiﬁed as vitamin D deﬁcient,
insufﬁcient, or sufﬁcient if they had a serum 25(OH)D concentra-
tion r20, between 21 and 29, or Z30 ng/mL, respectively. Serum
25(OH)D concentrations were not known during data collection.
The heparinized plasma samples mixed with oxalic acid were
analyzed for ascorbic acid concentrations (mg/dL) using spectro-
photometry (ARUP Laboratories). Serum tocopherol (α and γ)
concentrations (mg/L) were analyzed with high performance
liquid chromatography (HPLC; ARUP Laboratories). Serum α- and
β-carotenes, lutein, and zeaxanthin concentrations (mg/L) were
quantitated using HPLC (ARUP Laboratories).
Serum cytokine and CRP concentrations
The multiplex technology of Luminex (MAGPix; Austin, TX
USA) was used to analyze inﬂammatory cytokine concentrations
(pg/mL) with high-sensitivity. Serum high-sensitivity CRP concen-
trations (mg/L) were quantitated using immunoturbidimetry assay
(ARUP Laboratories).
Clinical chemistries
Serum rheumatoid factor concentrations (IU/mL) were quantitated
using an immunoturbidimetry assay and uric acid concentrations
(mg/dL) were determined using a quantitative spectrophotometry
assay (ARUP Laboratories). Serum parathyroid hormone intact (iPTH;
pg/mL) with calcium (mg/dL) concentrations were measured using an
electrochemiluminescent immunoassay (ARUP Laboratories).
Power calculation and statistical analysis
No previous study has investigated the role of vitamin D status
on quadricep strength in subjects with knee OA. Based on pilot
data from our lab, the power analysis indicated that in order to
detect a 6% difference in peak torque between vitamin D status
groups with a statistical power of 80% at the two-sided α¼0.05
level, at least 17 subjects were needed per group. Considering the
stringent inclusion criteria of radiographic evidence, pain, and
muscular weakness, and since the aforementioned symptoms can
occur independently from each other [59–65], we estimated
screening 102 subjects to achieve the targeted accrual in each
group (n¼17/group).
Fig. 1. Eligibility screening, study enrollment, and subject inclusion ﬂow chart.
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Data were checked for normality with a Shapiro–Wilk test prior
to statistical analysis. In order to achieve normality, rank (GM-CSF,
IFN-γ, IL-5, IL-6, IL-7, IL-8, TNF-α, CRP, α-carotene, β-carotene,
lutein, and zeaxanthin) or log (IL-12, IL-13, IL-1β, IL-2, and IL-4)
transformations were performed prior to statistical analyses.
Statistical signiﬁcance of subject characteristics (age, height, body
mass, BMI, serum 25(OH)D, rheumatoid factor, iPTH, and calcium)
were assessed with a one-way (vitamin D status) analysis of
variance (ANOVA) followed by a Tukey's post-hoc test when
appropriate. Statistical signiﬁcance of the cytokine, micronutrient,
and WOMAC data between vitamin D status groups were assessed
with a one-way (vitamin D status) analysis of covariance (ANCOVA)
followed by a Bonferroni post-hoc on multiple pairwise comparisons
when appropriate. Statistical signiﬁcance of leg strength data
was assessed with a two-way (vitamin D status and leg) ANCOVA
followed by a Bonferroni post-hoc test on multiple pairwise
comparisons when appropriate. Due to the sparse ﬁtting (i.e.,
frequency o5) in some of the cells, the association between
vitamin D status and the Kellgren–Lawrence grade were assessed
with a Goodman–Kruskal's gamma test. Relationships between
variables were examined with a Pearson Product Moment Linear
correlation. Gender, age, Kellgren–Lawrence grade, and body mass
index (BMI) served as a statistical covariates. Body mass was not
included as a covariate due to multicollinearity with BMI. Sig-
niﬁcance was set at po0.05. All statistical analyses were per-
formed with SYSTAT (version 13.1, Chicago, IL USA). Data presented
as mean7SEM unless otherwise noted.
Results
Subject characteristics
Following eligibility screening, 73 subjects were enrolled and
assessed for study inclusion (Fig. 1). Of the 73 enrolled, 56 subjects
(age, 4871 y; height, 16871 cm; body mass, 94.172.8 kg; BMI,
33.070.9 kg/m2; serum 25(OH)D, 25.871.1 ng/mL) met the sub-
ject inclusion criteria.
Age, height, plasma rheumatoid factor, plasma calcium, and
WOMAC pain and physical function scores were not signiﬁcantly
different between vitamin D groups (Table 1). However, serum 25
(OH)D concentrations inversely correlated with pain (n¼56,
r¼0.27, po0.05) and physical function (n¼56, r¼0.28,
po0.05) (Fig. 2A and B), suggesting decreases in self-reported
knee pain and physical function with an increase in serum 25(OH)
D concentrations. Body mass, BMI, plasma iPTH (Table 1), and
plasma uric acid (Fig. 3A) were signiﬁcantly (all po0.05) increased
in the vitamin D deﬁcient group. Approximately 9% of the subjects
displayed a Kellgren–Lawrence grade of 2, while 68% and 23% of
the subjects had a grade 3 or 4 score, respectively (Table 1).
Importantly, the Kellgren–Lawrence scores were not signiﬁcantly
different between groups, suggesting that the severity of knee
osteoarthritis was similar between groups.
Circulating chemistries
Despite trends, circulating α-carotene, β-carotene, lutein, zeax-
anthin, ascorbic acid, and α-tocopherol were not signiﬁcantly
different between groups after adjusting for BMI and other
covariates (Table 2). In contrast, serum γ-tocopherol concentra-
tions were signiﬁcantly (po0.05) increased (94% vs. vitamin D
sufﬁcient and 13% vs. vitamin D insufﬁcient) in the vitamin D
deﬁcient group (Fig. 3B). In the vitamin D sufﬁcient group, serum
γ-tocopherol inversely correlated (r¼0.47, po0.05) with serum
TNF-α (Table 3), suggesting a pro-inﬂammatory increase with a
γ-tocopherol decrease despite a sufﬁcient serum 25(OH)D con-
centration. Circulating cytokine and CRP concentrations were not
signiﬁcantly different between groups (Table 2).
Isokinetic leg strength data
Concentric-knee extension peak torque, average power, and total
work were signiﬁcantly (all po0.05) decreased and concentric-knee
extension deceleration was signiﬁcantly (po0.05) slower in the
vitamin D deﬁcient group (Figs. 4A–D). Concentric-knee ﬂexion
deceleration was signiﬁcantly slower in the symptomatic compared
to the non-symptomatic leg, but differences between vitamin D
groups were not signiﬁcant (Table 4). Concentric-knee ﬂexion
torque, power, work, and acceleration were not signiﬁcantly differ-
ent between vitamin D groups.
Discussion
Muscular weakness is a major impairment that hinders the
quality of life and activities of daily living in those with and
without knee OA. The major ﬁnding of the present investigation
was that vitamin D deﬁciency associated with quadricep weak-
ness, and that an increase in serum 25(OH)D correlated with a
decrease in perceived physical dysfunction in subjects with knee
OA. The present report also provides original data suggesting that
vitamin D deﬁciency is not associated with an increase in inﬂam-
matory cytokines or a decrease in micronutrients that modulate
inﬂammatory cytokines. However, the γ-tocopherol decrease with
vitamin D sufﬁciency correlated with a TNF-α increase in subjects
with knee OA, suggesting an anti-inﬂammatory role of vitamin E
in a pathophysiological condition mediated by inﬂammation and
in subjects with sufﬁcient vitamin D.
Quadriceps weakness is a common and early symptom of knee OA
that predicts and occurs before radiographic evidence of knee OA and
knee pain [10,11]. Although previous studies illustrate the association
between low serum 25(OH)D concentrations and muscular weakness
across a range of physiological and pathophysiological conditions in
humans, this study provides unique data indicating that vitamin D
deﬁciency associates with quadricep weakness in subjects with knee
Table 1
Subject characteristics and clinical chemistries.
Vitamin D status
Deﬁcient Insufﬁcient Sufﬁcient p-value
n (males:females) 17 (9:8) 21 (9:12) 18 (7:11)
Age (y) 5173 4872 4773 0.536
Height (cm) 16772 17072 16872 0.487
Body mass (kg) 100.675.4 99.774.6 81.473.3a,b 0.006
BMI (kg/m2) 36.071.8 34.271.3 28.670.8a,b 0.001
Serum 25(OH)D (ng/ml) 16.370.7 24.770.6a 36.070.8a,b o0.001
Rheumatoid factor (IU/ml) 9.1870.46 8.9570.44 8.8370.45 0.599
iPTH (pg/mL) 50.173.8 44.173.6 33.672.2a,c 0.004
Calcium (mg/dL) 9.3570.13 9.2970.1 9.4970.10 0.632
WOMAC pain (0–20) 9.4771.03 7.6070.63 6.6970.82 0.320
WOMAC function (0–68) 30.173.4 24.772.4 19.772.5 0.461
Kellgren–Lawrence grade 0.468
2 (n) 1 4 0
3 (n) 14 9 15
4 (n) 2 8 3
Data presented as mean7SEM unless otherwise noted.
All subjects were Caucasian.
a po0.05 vs. deﬁcient.
b po0.05 vs. insufﬁcient.
c p¼0.07 vs. insufﬁcient.
T. Barker et al. / Redox Biology 2 (2014) 466–474 469
OA. Additionally, vitamin D deﬁciency associated with slower
concentric-knee extension deceleration times, which implies a decre-
ment in the eccentric control of the quadriceps with low serum 25
(OH)D concentrations. As proposed elsewhere [8,66], weakness and
impaired eccentric control of the quadriceps is detrimental to the
structural integrity of the knee joint by minimizing shock absorption.
Therefore, altering serum 25(OH)D concentrations could be an
attractive therapeutic approach to attenuate quadriceps weakness,
which importantly, contributes to knee OA.
Perceived physical function is impaired in elderly with vitamin
D deﬁciency. In knee OA subjects, studies investigating the
association between vitamin D and physical function are scarce.
Using Lequesne's indices to assess physical function in subjects
with knee OA, Al-Jarallah et al. [5] reported that serum 25(OH)D
concentrations did not associate with physical function. In an
intervention study, supplemental vitamin D (2000 IU/d for 2 y)
increased serum 25(OH)D concentrations without improving phy-
sical function, such as standing from a chair or a 20-m walk, in
subjects with knee OA [24]. Consistent with those results, per-
ceived physical function was not signiﬁcantly different between
patients with contrasting serum 25(OH)D concentrations in the
present investigation. However, serum 25(OH)D concentrations
inversely correlated with physical dysfunction, suggesting an
improvement in physical function with an increase in serum 25
(OH)D concentrations. The discrepancy between the group com-
parisons and correlative ﬁndings regarding the association
between vitamin D and physical function possibly suggest a
narrow range in serum 25(OH)D concentrations or that the
demarcation between vitamin D status levels were inappropriately
deﬁned to delineate a signiﬁcant difference in self-reported
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Fig. 2. Serum 25(OH)D concentrations correlated with pain and physical function. Serum 25(OH)D concentrations (ng/mL) inversely correlated with pain (n¼56, r¼0.27,
po0.05) and physical function (n¼56, r¼0.28, po0.05). Vitamin D deﬁcient, red circles; vitamin D insufﬁcient, yellow circles; vitamin D sufﬁcient, green circles.
Fig. 3. Plasma uric acid and serum γ-tocopherol concentrations. (A) Plasma uric acid concentrations (mg/dL) were signiﬁcantly (bar, po0.05) increased in the vitamin D
deﬁcient group compared to the vitamin D sufﬁcient group. (B) Serum γ-tocopherol concentrations (mg/L) were signiﬁcantly (bars, po0.05) increased in the vitamin D
deﬁcient group compared to those in the insufﬁcient and sufﬁcient groups. Def, vitamin D deﬁcient (red); Insuff, vitamin D insufﬁcient (yellow); Suff, vitamin D sufﬁcient
(green). Data presented as mean7SEM.
Table 2
Circulating vitamin and cytokine concentrations.
Vitamin D status
Deﬁcient Insufﬁcient Sufﬁcient p-value
α-Carotene (μg/L) 47.577.1 55.877.2 87.3717.1 0.646
β-Carotene (μg/L) 99.9710.8 169.1728.6 271.0749.6 0.122
Lutein (μg/L) 102715 119714 138716 0.832
Zeaxanthin (μg/L) 25.973.6 29.573.0 29.572.8 0.535
Ascorbic acid (mg/dl) 0.8970.12 1.2070.11 1.1370.09 0.176
α-Tocopherol (mg/L) 11.370.8 11.270.6 11.470.7 0.941
GM-CSF (pg/mL) 1.3270.34 4.3071.75 2.7471.00 0.864
IFN-γ (pg/mL) 10.472.53 18.974.27 16.376.59 0.216
TNF-α (pg/mL) 5.7670.71 5.4370.53 5.2871.07 0.660
IL-1β (pg/mL) 0.6670.22 0.9570.30 1.1670.45 0.526
IL-2 (pg/mL) 1.3170.44 2.2070.64 2.5470.86 0.423
IL-4 (pg/mL) 16.475.63 30.9711.5 25.5711.7 0.920
IL-5 (pg/mL) 0.1470.05 0.7970.27 0.3870.16 0.269
IL-6 (pg/mL) 1.5270.15 2.8370.58 1.5070.25 0.185
IL-7 (pg/mL) 6.8071.04 7.4471.11 8.7071.54 0.694
IL-8 (pg/mL) 6.7070.53 8.3771.15 5.7570.57 0.536
IL-10 (pg/mL) 19.873.10 42.1716.1 25.974.25 0.249
IL-12 (pg/mL) 1.6470.69 7.3574.40 5.2273.20 0.248
IL-13 (pg/mL) 10.972.95 14.974.13 10.673.74 0.635
CRP (mg/L) 3.3870.72 4.6171.31 2.3270.57 0.365
Data presented as mean7SEM.
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physical function. In agreement with the latter postulate, Houston
et al. [12] reported that the serum 25(OH)D concentration for
improved physical function (28–32 ng/mL) was greater than that
for muscular strength (22–28 ng/mL) in elderly.
Despite vitamin D deﬁciency, circulating cytokine concentrations
were similar between vitamin D groups. In a population whose
degenerative joint condition is mediated in part by pro-inﬂammatory
cytokines, it appears that low vitamin D does not increase inﬂam-
matory cytokines in the blood. This ﬁnding, however, conﬂicts with
results showing a circulating increase of pro-inﬂammatory cytokines
in young reportedly healthy adults [36], obese adults [37], chronic
heart failure patients [38], and type 2 diabetics [39] with low serum
25(OH)D concentrations. Further, a pro-inﬂammatory cytokine
increase in the blood associates with muscular weakness and
impaired physical mobility in elderly [67–70], the development of
knee OA [28,71], and muscular weakness in patients with knee OA
[9]. Based on those ﬁndings, we anticipated vitamin D deﬁciency to
associate with muscular weakness and a cytokine increase in the
blood. In contrast, the data here suggest that vitamin D deﬁciency
associates with muscular weakness but not serum cytokines in
subjects with knee OA.
Similar to vitamin D, other dietary micronutrients (e.g., β-
carotene, ascorbic acid, and α- and γ-tocopherol's) modulate
inﬂammatory cytokines. Surprisingly, no study has reported pre-
viously the level of other micronutrients concomitantly with
serum 25(OH)D when investigating the role of vitamin D status
on inﬂammatory cytokines. Although α- and β-carotene's, lutein,
zeaxanthin, ascorbic acid, and α-tocopherol were not signiﬁcantly
different between groups, serum γ-tocopherol concentrations
were signiﬁcantly increased with vitamin D deﬁciency. The expla-
nation for the γ-tocopherol increase with vitamin D deﬁciency is
Table 3
Serum γ-T and cytokine correlation coefﬁcients.
Vitamin D status
Deﬁcient Insufﬁcient Sufﬁcient Group
γ-T γ-T γ-T γ-T
GM-CSF 0.04 0.13 0.21 0.01
IFN-γ 0.12 0.02 0.31 0.04
TNF-α 0.15 0.00 0.47† 0.03
IL-1β 0.03 0.19 0.22 0.00
IL-2 0.07 0.15 0.15 0.05
IL-4 0.18 0.23 0.21 0.02
IL-5 0.22 0.14 0.28 0.09
IL-6 0.35 0.06 0.20 0.08
IL-7 0.18 0.15 0.06 0.04
IL-8 0.10 0.16 0.25 0.15
IL-10 0.35 0.06 0.10 0.04
IL-12 0.15 0.23 0.29 0.06
IL-13 0.29 0.28 0.05 0.08
γ-T, γ-tocopherol.
Group, all subjects combined.
† po0.05.
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Fig. 4. Isokinetic-concentric knee extension peak torque, average power, total work, and deceleration in the symptomatic and non-symptomatic legs. (A) Peak torque (Nm)
was signiﬁcantly decreased in the symptomatic leg (#po0.05 vs. non-symptomatic leg) and in the vitamin D deﬁcient group (bar, po0.05). (B) Average power (W) was
signiﬁcantly decreased in the symptomatic leg (#po0.05 vs. non-symptomatic leg) and in the vitamin D deﬁcient group (bar, po0.05). (C) Total work (J) was signiﬁcantly
decreased in the symptomatic leg (#po0.05 vs. non-symptomatic leg) and in the vitamin D deﬁcient group (bar, po0.05). (D) Deceleration (m/s) was signiﬁcantly slower in
the vitamin D deﬁcient group compared to that in the vitamin D insufﬁcient and sufﬁcient groups (bars, po0.05). Def, vitamin D deﬁcient (red); Insuff, vitamin D insufﬁcient
(yellow); Suff, vitamin D sufﬁcient (green); Symptomatic leg (colored diamonds, ♢); Non-symptomatic leg (colored circles, ○). Figure legend provided in ‘A’. Data presented
as mean7SEM.
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unknown and awaits future resolve, but it is plausible that the
serum γ-tocopherol difference between groups is related to dis-
parate dietary habits as γ-tocopherol is the most abundant form of
vitamin E in the American diet [72,73].
As mentioned previously, pro-inﬂammatory cytokines are
increased in various pathophysiological conditions with low vita-
min D [38,39], and similar to vitamin D, γ-tocopherol is a potent
anti-inﬂammatory micronutrient [74]. γ-Tocopherol inhibits cyto-
kine production by decreasing 5-lipoxygenase, cyclooxygenase-2,
and NF-κB activation and impairing jun terminal kinase and
extracellular signal-regulated kinases 1/2 phosphorylation
[44,75–77]. Based on the cytokine modulating properties of both
vitamin D and E, it is plausible that contrasting or divergent
micronutrient levels (e.g., high vitamin D and low vitamin E)
could inﬂuence cytokine levels in the blood. Indeed, serum TNF-α
inversely correlated with γ-tocopherol in the vitamin D sufﬁcient
group with low serum γ-tocopherol (Table 3). This ﬁnding indi-
cates that a decrease in γ-tocopherol could increase a
pro-inﬂammatory cytokine despite a sufﬁcient serum 25(OH)D
concentration in subjects with knee OA. Given the similar cyto-
kine, carotenoid, ascorbic acid, and α-tocopherol concentrations
between groups, we speculate that the anti-inﬂammatory prop-
erty of γ-tocopherol is balancing the serum cytokine concentra-
tions in the vitamin D deﬁcient group compared to those with
insufﬁcient and sufﬁcient vitamin D. This speculation, however,
warrants future investigation. Results from future studies could
advance our knowledge pertaining to the anti-inﬂammatory role
of vitamin E in vitamin D deﬁcient patients suffering from knee
OA, a degenerative joint condition mediated in part by pro-
inﬂammatory cytokines, including but not limited to TNF-α [78].
Plasma uric acid increases with the prevalence of knee arthritis
[79], and in this study, plasma uric acid concentrations increased
in knee OA subjects with vitamin D deﬁciency. A chronic increase
in plasma uric acid is a risk factor for cardiovascular disease, gout,
renal failure, and metabolic syndrome. However, an acute increase
of uric acid might possess an antioxidant property. Antioxidants
prevent the reactive oxygen species-mediated activation of intra-
cellular redox-sensitive signaling pathways that induce cytokine
expression. The antioxidant property of uric acid could explain the
similar cytokine concentrations between vitamin D groups. Unfor-
tunately, due to the cross-sectional design of this study, it is
unclear if the increase in uric acid with vitamin D deﬁciency was
acute or chronic.
The explanation for an increase in uric acid is lower excretion,
increase synthesis, or both. Serum uric acid concentrations also
increase with serum PTH concentrations [80,81], and vitamin D
deﬁciency or insufﬁciency increases PTH concentrations [82]. In
the vitamin D deﬁcient group here, the increase in plasma uric
acid occurred in parallel with an increase in plasma iPTH. It is
plausible, therefore, that the increase in iPTH concentrations with
vitamin D deﬁciency is stimulating an increase in uric acid.
However, it is reasonable that other factors are contributing to
the uric acid increase with vitamin D deﬁciency as well.
A limitation of this study is the lack of dietary data that could
reveal the impact of micronutrient intake on blood 25(OH)D and
other micronutrient concentrations. Along these lines, there were
apparent decreases in α- and β-carotene's, lutein, and ascorbic acid
with vitamin D deﬁciency. These decreases, however, were not
signiﬁcant after adjusting for BMI and other covariates. In addition,
it is plausible that the contrasting serum 25(OH)D concentrations
could be the product of differences in lifestyle habits. Future
studies are encouraged to include dietary, lifestyle, and other
circulating micronutrient analyses when investigating the role of
vitamin D on inﬂammatory cytokines and skeletal muscle strength
in conditions associated with systemic inﬂammation. Another
limitation of this study includes the selected age range in subjects
with modest activity levels. Thus, caution is recommended when
extrapolating these ﬁndings to other populations. This study also
consisted of a cross-sectional design that precludes potential
inference on causality. Finally, this was a small sample size study,
but in addition to its original ﬁndings, these data are valuable in
generating new hypotheses.
In summary, muscular weakness and cytokines alter the
mechanical stability and inﬂammatory environment in the knee,
respectively, and contribute to the pathogenesis of OA. In the
present investigation, vitamin D deﬁciency associated with
Table 4
Symptomatic and non-symptomatic isokinetic leg strength data.
Vitamin D status Vitamin D status
main effect p-value
Deﬁcient Insufﬁcient Sufﬁcient
Concentric knee extension (60 1/s)
Symptomatic acceleration (m/s) 62.477.0 56.375.7 52.874.4 0.071
Non-symptomatic acceleration (m/s) 70.679.7 54.375.2 43.374.6
Leg main effect p-value 0.835
Concentric knee ﬂexion (60 1/s)
Symptomatic peak torque (Nm) 59.476.0 78.277.9 78.879.7 0.127
Non-symptomatic peak torque (Nm) 72.574.6 84.776.5 83.7711.7
Leg main effect p-value 0.224
Sympomatic average power (W) 35.674.2 46.075.6 48.675.9 0.800
Non-symptomatic average power (W) 87.1743.8 55.574.7 51.775.6
Leg main effect p-value 0.122
Symptomatic total work (J) 68.677.0 102.0711.5 105.0716.7 0.097
Non-symptomatic total work (J) 87.376.3 105.079.0 108.8719.6
Leg main effect p-value 0.414
Symptomatic acceleration (m/s) 85.6712.2 86.4714.2 71.174.7 0.791
Non-symptomatic acceleration (m/s) 62.474.7 58.674.3 52.873.0
Leg main effect p-value 0.213
Symptomatic deceleration (m/s) 175718 153714 148714 0.543
Non-symptomatic deceleration (m/s) 134718 126711 119714
Leg main effect p-value 0.009
Data presented as mean7SEM.
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quadriceps dysfunction but not inﬂammatory cytokines in subjects
with knee OA. We propose that the increase in γ-tocopherol with
vitamin D deﬁciency could abrogate a cytokine increase and
consequentially result in similar cytokine levels between vitamin
D groups. In support of this premise, a decrease in γ-tocopherol
correlated with an increase in TNF-α in the vitamin D sufﬁcient
group. We conclude that vitamin D deﬁciency associates with
quadriceps dysfunction and an increase in γ-tocopherol, and that
γ-tocopherol could have an important anti-inﬂammatory role in
subjects with vitamin D sufﬁciency.
Acknowledgments
We would like to thank all the subjects that participated in this
study. This study was funded in part by USANA Health Sciences,
Inc. (Salt Lake City, UT USA) (TB).
References
[1] T.E. McAlindon, D.T. Felson, Y. Zhang, M.T. Hannan, P. Aliabadi, B. Weissman,
D. Rush, P.W. Wilson, P. Jacques, Relation of dietary intake and serum levels of
vitamin D to progression of osteoarthritis of the knee among participants in
the Framingham study, Ann. Intern. Med. 125 (1996) 353–359.
[2] B. Heidari, P. Heidari, K. Hajian-Tilaki, Association between serum vitamin D
deﬁciency and knee osteoarthritis, Int. Orthop. 35 (2010) 1627–1631.
[3] S. Muraki, E. Dennison, K. Jameson, B.J. Boucher, T. Akune, N. Yoshimura,
A. Judge, N.K. Arden, K. Javaid, C. Cooper, Association of vitamin D status with
knee pain and radiographic knee osteoarthritis, Osteoarthr. Cartil. 19 (2011)
1301–1306.
[4] C. Ding, F. Cicuttini, V. Parameswaran, J. Burgess, S. Quinn, G. Jones, Serum
levels of vitamin D, sunlight exposure, and knee cartilage loss in older adults:
the Tasmanian older adult cohort study, Arthritis Rheum. 60 (2009)
1381–1389.
[5] K.F. Al-Jarallah, D. Shehab, A. Al-Awadhi, I. Nahar, M.Z. Haider, M.A. Moussa,
Are 25(OH)D levels related to the severity of knee osteoarthritis and function?
Med. Princ. Pract. 21 (2011) 74–78.
[6] D.T. Felson, J. Niu, M. Clancy, P. Aliabadi, B. Sack, A. Guermazi, D.J. Hunter,
S. Amin, G. Rogers, S.L. Booth, Low levels of vitamin D and worsening of knee
osteoarthritis: results of two longitudinal studies, Arthritis Rheum. 56 (2007)
129–136.
[7] S. Konstari, M. Paananen, M. Heliovaara, P. Knekt, J. Marniemi, O. Impivaara,
J. Arokoski, J. Karppinen, Association of 25-hydroxyvitamin D with the
incidence of knee and hip osteoarthritis: a 22-year follow-up study, Scand. J
Rheumatol. 41 (2011) 124–131.
[8] M.V. Hurley, D.L. Scott, Improvements in quadriceps sensorimotor function
and disability of patients with knee osteoarthritis following a clinically
practicable exercise regime, Br. J. Rheumatol. 37 (1998) 1181–1187.
[9] M.L. Santos, W.F. Gomes, D.S. Pereira, D.M. Oliveira, J.M. Dias, E. Ferrioli, L.
S. Pereira, Muscle strength, muscle balance, physical function and plasma
interleukin-6 (IL-6) levels in elderly women with knee osteoarthritis (OA),
Arch. Gerontol. Geriatr. 52 (2011) 322–326.
[10] C. Slemenda, K.D. Brandt, D.K. Heilman, S. Mazzuca, E.M. Braunstein, B.P. Katz,
F.D. Wolinsky, Quadriceps weakness and osteoarthritis of the knee, Ann.
Intern. Med. 127 (1997) 97–104.
[11] N.M. Fisher, D.R. Pendergast, G.E. Gresham, E. Calkins, Muscle rehabilitation:
its effect on muscular and functional performance of patients with knee
osteoarthritis, Arch. Phys. Med. Rehabil. 72 (1991) 367–374.
[12] D.K. Houston, J.A. Tooze, R.H. Neiberg, D.B. Hausman, M.A. Johnson, J.A. Cauley,
D.C. Bauer, P.M. Cawthon, M.K. Shea, G.G. Schwartz, J.D. Williamson, F.
A. Tylavsky, M. Visser, E.M. Simonsick, T.B. Harris, S.B. Kritchevsky, 25-
hydroxyvitamin D status and change in physical performance and strength
in older adults: the health, aging, and body composition study, Am. J.
Epidemiol. 176 (2012) 1025–1034.
[13] H.A. Bischoff-Ferrari, T. Dietrich, E.J. Orav, F.B. Hu, Y. Zhang, E.W. Karlson,
B. Dawson-Hughes, Higher 25-hydroxyvitamin D concentrations are asso-
ciated with better lower-extremity function in both active and inactive
persons aged4or¼60 y, Am. J. Clin. Nutr. 80 (2004) 752–758.
[14] S.R. Mastaglia, M. Seijo, D. Muzio, J. Somoza, M. Nunez, B. Oliveri, Effect of
vitamin D nutritional status on muscle function and strength in healthy
women aged over sixty-ﬁve years, J. Nutr. Health Aging 15 (2011) 349–354.
[15] I.S. Wicherts, N.M. van Schoor, A.J. Boeke, M. Visser, D.J. Deeg, J. Smit, D.L. Knol,
P. Lips, Vitamin D status predicts physical performance and its decline in older
persons, J. Clin. Endocrinol. Metab. 92 (2007) 2058–2065.
[16] M. Visser, D.J. Deeg, P. Lips, Low vitamin D and high parathyroid hormone
levels as determinants of loss of muscle strength and muscle mass (sarcope-
nia): the longitudinal aging study Amsterdam, J. Clin. Endocrinol. Metab. 88
(2003) 5766–5772.
[17] J.K. Dhesi, L.M. Bearne, C. Moniz, M.V. Hurley, S.H. Jackson, C.G. Swift, T.
J. Allain, Neuromuscular and psychomotor function in elderly subjects who fall
and the relationship with vitamin D status, J. Bone Miner. Res. 17 (2002)
891–897.
[18] L. Ceglia, Vitamin D and skeletal muscle tissue and function, Mol. Asp. Med. 29
(2008) 407–414.
[19] R.L. Boland, VDR activation of intracellular signaling pathways in skeletal
muscle, Mol. Cell Endocrinol. 347 (2011) 11–16.
[20] H.A. Bischoff-Ferrari, B. Dawson-Hughes, E. Stocklin, E. Sidelnikov, W.
C. Willett, E.J. Orav, H.B. Stahelin, S. Wolfram, A. Jetter, J. Schwager,
J. Henschkowski, E.A. von, A. Egli, Oral supplementation with 25(OH)D
(3) versus vitamin D(3): effects on 25(OH)D levels, lower extremity function,
blood pressure and markers of innate immunity, J. Bone Miner. Res. (2011).
[21] Y. Sato, J. Iwamoto, T. Kanoko, K. Satoh, Low-dose vitamin D prevents muscular
atrophy and reduces falls and hip fractures in women after stroke: a
randomized controlled trial, Cerebrovasc. Dis. 20 (2005) 187–192.
[22] C. Annweiler, A.M. Schott-Petelaz, G. Berrut, R.W. Kressig, S. Bridenbaugh, F.
R. Herrmann, O. Beauchet, Vitamin D deﬁciency-related quadriceps weakness:
results of the epidemiologie De l'Osteoporose cohort, J. Am. Geriatr. Soc. 57
(2009) 368–369.
[23] A.M. Kenny, B. Biskup, B. Robbins, G. Marcella, J.A. Burleson, Effects of vitamin
D supplementation on strength, physical function, and health perception in
older, community-dwelling men, J. Am. Geriatr. Soc. 51 (2003) 1762–1767.
[24] T. McAlindon, M. LaValley, E. Schneider, M. Nuite, J.Y. Lee, L.L. Price, G. Lo,
B. Dawson-Hughes, Effect of vitamin D supplementation on progression of
knee pain and cartilage volume loss in patients with symptomatic osteoar-
thritis: a randomized controlled trial, J. Am. Med. Assoc. 309 (2013) 155–162.
[25] M. Sowers, M. Jannausch, E. Stein, D. Jamadar, M. Hochberg, L. Lachance,
C-reactive protein as a biomarker of emergent osteoarthritis, Osteoarthr.
Cartil. 10 (2002) 595–601.
[26] T.D. Spector, D.J. Hart, D. Nandra, D.V. Doyle, N. Mackillop, J.R. Gallimore, M.
B. Pepys, Low-level increases in serum C-reactive protein are present in early
osteoarthritis of the knee and predict progressive disease, Arthritis Rheum. 40
(1997) 723–727.
[27] J.P. Pelletier, J.P. Raynauld, J. Caron, F. Mineau, F. Abram, M. Dorais, B. Haraoui,
D. Choquette, J. Martel-Pelletier, Decrease in serum level of matrix metallo-
proteinases is predictive of the disease-modifying effect of osteoarthritis drugs
assessed by quantitative MRI in patients with knee osteoarthritis, Ann.
Rheum. Dis. 69 (2010) 2095–2101.
[28] O. Stannus, G. Jones, F. Cicuttini, V. Parameswaran, S. Quinn, J. Burgess, C. Ding,
Circulating levels of IL-6 and TNF-alpha are associated with knee radiographic
osteoarthritis and knee cartilage loss in older adults, Osteoarthr. Cartil. 18
(2010) 1441–1447.
[29] G. Livshits, G. Zhai, D.J. Hart, B.S. Kato, H. Wang, F.M. Williams, T.D. Spector,
Interleukin-6 is a signiﬁcant predictor of radiographic knee osteoarthritis: the
Chingford study, Arthritis Rheum. 60 (2009) 2037–2045.
[30] M.D. Smith, S. Triantaﬁllou, A. Parker, P.P. Youssef, M. Coleman, Synovial
membrane inﬂammation and cytokine production in patients with early
osteoarthritis, J. Rheumatol. 24 (1997) 365–371.
[31] A.D. Pearle, C.R. Scanzello, S. George, L.A. Mandl, E.F. DiCarlo, M. Peterson,
T.P. Sculco, M.K. Crow, Elevated high-sensitivity C-reactive protein levels are
associated with local inﬂammatory ﬁndings in patients with osteoarthritis,
Osteoarthr. Cartil. 15 (2007) 516–523.
[32] S. Devaraj, J.M. Yun, C.R. Duncan-Staley, I. Jialal, Low vitamin D levels correlate
with the proinﬂammatory state in type 1 diabetic subjects with and without
microvascular complications, Am. J. Clin. Pathol. 135 (2011) 429–433.
[33] A.L. Khoo, L.Y. Chai, H.J. Koenen, F.C. Sweep, I. Joosten, M.G. Netea, A.J. van der
Ven, Regulation of cytokine responses by seasonality of vitamin D status in
healthy individuals, Clin. Exp. Immunol. 164 (2011) 72–79.
[34] T. Barker, Vitamin D and inﬂammation, in: M.L. Garg, L.G. Wood (Eds.),
Nutrition & Physical Activity in Inﬂammatory Diseases, CABI, Boston, 2013,
pp. 75–86.
[35] A.S. Dusso, A.J. Brown, E. Slatopolsky, D. Vitamin, Am. J. Physiol. Ren. Physiol.
289 (2005) F8–28.
[36] T. Barker, T.B. Martins, H.R. Hill, C.R. Kjeldsberg, B.M. Dixon, E.D. Schneider,
V.T. Henriksen, L.K. Weaver, Circulating pro-inﬂammatory cytokines are
elevated and peak power output correlates with 25-hydroxyvitamin D in
vitamin D insufﬁcient adults, Eur. J. Appl. Physiol. 113 (2013) 1523–1534.
[37] A. Bellia, C. Garcovich, M. D'Adamo, M. Lombardo, M. Tesauro, G. Donadel,
P. Gentileschi, D. Lauro, M. Federici, R. Lauro, P. Sbraccia, Serum 25-
hydroxyvitamin D levels are inversely associated with systemic inﬂammation
in severe obese subjects, Intern. Emerg. Med. 8 (2013) 33–40.
[38] M. Milovanovic, G. Pesic, V. Nikolic, T. Jevtovic-Stoimenov, K. Vasic, Z. Jovic,
M. Deljanin-Ilic, S. Pesic, Vitamin D deﬁciency is associated with increased IL-
17 and TNFalpha levels in patients with chronic heart failure, Arq. Bras.
Cardiol. 98 (2012) 259–265.
[39] S. Shab-Bidar, T.R. Neyestani, A. Djazayery, M.R. Eshraghian, A. Houshiarrad,
A. Kalayi, N. Shariatzadeh, N. Khalaji, A. Gharavi, Improvement of vitamin D
status resulted in amelioration of biomarkers of systemic inﬂammation in the
subjects with type 2 diabetes, Diabetes Metab. Res. Rev. 28 (2012) 424–430.
[40] E. Mah, R. Pei, Y. Guo, K.D. Ballard, T. Barker, V.E. Rogers, B.A. Parker, A.
W. Taylor, M.G. Traber, J.S. Volek, R.S. Bruno, Gamma-tocopherol-rich supple-
mentation additively improves vascular endothelial function during smoking
cessation, Free Radic. Biol. Med. 65C (2013) 1291–1299.
[41] S. Devaraj, S. Leonard, M.G. Traber, I. Jialal, Gamma-tocopherol supplementa-
tion alone and in combination with alpha-tocopherol alters biomarkers of
oxidative stress and inﬂammation in subjects with metabolic syndrome, Free
Radic. Biol. Med. 44 (2008) 1203–1208.
T. Barker et al. / Redox Biology 2 (2014) 466–474 473
[42] S. Devaraj, I. Jialal, Low-density lipoprotein postsecretory modiﬁcation, mono-
cyte function, and circulating adhesion molecules in type 2 diabetic patients
with and without macrovascular complications: the effect of {alpha}-
tocopherol supplementation, Circulation 102 (2000) 191–196.
[43] A. England, A.M. Valdes, J.L. Slater-Jefferies, R. Gill, W.M. Howell, P.C. Calder, R.
F. Grimble, Variants in the genes encoding TNF-alpha, IL-10, and GSTP1
inﬂuence the effect of alpha-tocopherol on inﬂammatory cell responses in
healthy men, Am. J. Clin. Nutr. 95 (2012) 1461–1467.
[44] J. Wiser, N.E. Alexis, Q. Jiang, W. Wu, C. Robinette, R. Roubey, D.B. Peden, In
vivo gamma-tocopherol supplementation decreases systemic oxidative stress
and cytokine responses of human monocytes in normal and asthmatic
subjects, Free Radic. Biol. Med. 45 (2008) 40–49.
[45] C. Hartel, T. Strunk, P. Bucsky, C. Schultz, Effects of vitamin C on intracyto-
plasmic cytokine production in human whole blood monocytes and lympho-
cytes, Cytokine 27 (2004) 101–106.
[46] R.H. Prabhala, L.M. Braune, H.S. Garewal, R.R. Watson, Inﬂuence of beta-
carotene on immune functions, Ann. N. Y. Acad. Sci. 691 (1993) 262–263.
[47] D.A. Hughes, A.J. Wright, P.M. Finglas, A.C. Peerless, A.L. Bailey, S.B. Astley,
A.C. Pinder, S. Southon, The effect of beta-carotene supplementation on the
immune function of blood monocytes from healthy male nonsmokers, J. Lab.
Clin. Med. 129 (1997) 309–317.
[48] D.A. Hughes, P.M. Finglas, A.J. Wright, A.C. Peerless, A.L. Bailey, S.B. Astley,
S. Southon, Dietary beta-carotene supplementation modulates the production
of tumour necrosis factor-alpha by human monocytes, Biochem. Soc. Trans. 24
(1996) 387S.
[49] A. Duncan, D. Talwar, D.C. McMillan, F. Stefanowicz, D.S. O'Reilly, Quantitative
data on the magnitude of the systemic inﬂammatory response and its effect
on micronutrient status based on plasma measurements, Am. J. Clin. Nutr. 95
(2012) 64–71.
[50] T.P. Erlinger, E. Guallar, E.R. Miller , R. Stolzenberg-Solomon, L.J. Appel,
Relationship between systemic markers of inﬂammation and serum beta-
carotene levels, Arch. Intern. Med. 161 (2001) 1903–1908.
[51] C.R. D'Adamo, R.R. Miller, M.D. Shardell, D.L. Orwig, M.C. Hochberg, L. Ferrucci,
R.D. Semba, J.A. Yu-Yahiro, J. Magaziner, G.E. Hicks, Higher serum concentra-
tions of dietary antioxidants are associated with lower levels of inﬂammatory
biomarkers during the year after hip fracture, Clin. Nutr. 31 (2012) 659–665.
[52] T. Barker, T.B. Martins, C.R. Kjeldsberg, R.H. Trawick, H.R. Hill, Circulating
interferon-gamma correlates with 1,25(OH)D and the 1,25(OH)D-to-25(OH)D
ratio, Cytokine 60 (2012) 23–26.
[53] T. Barker, S.W. Leonard, R.H. Trawick, T.B. Martins, C.R. Kjeldsberg, H.R. Hill,
M.G. Traber, Modulation of inﬂammation by vitamin E and C supplementation
prior to anterior cruciate ligament surgery, Free. Radic. Biol. Med. 46 (2009)
599–606.
[54] V.T. Henriksen, V.E. Rogers, G.L. Rasmussen, R.H. Trawick, N.G. Momberger,
D. Aguirre, T. Barker, Pro-inﬂammatory cytokines mediate the decrease in
serum 25(OH)D concentrations after total knee arthroplasty? Med. Hypoth-
eses 82 (2014) 134–137.
[55] D. Reid, B.J. Toole, S. Knox, D. Talwar, J. Harten , J.O., S. Blackwell, J. Kinsella,
D.C. McMillan, A.M. Wallace, The relation between acute changes in the
systemic inﬂammatory response and plasma 25-hydroxyvitamin D concen-
trations after elective knee arthroplasty, Am. J. Clin. Nutr. 93 (2011)
1006–1011.
[56] J.A. Louw, A. Werbeck, M.E. Louw, T.J. Kotze, R. Cooper, D. Labadarios, Blood
vitamin concentrations during the acute-phase response, Crit. Care Med. 20
(1992) 934–941.
[57] N. Bellamy, W.W. Buchanan, C.H. Goldsmith, J. Campbell, L.W. Stitt, Validation
study of WOMAC: a health status instrument for measuring clinically
important patient relevant outcomes to antirheumatic drug therapy in
patients with osteoarthritis of the hip or knee, J. Rheumatol. 15 (1988)
1833–1840.
[58] J.H. Kellgren, J.S. Lawrence, Radiological assessment of osteo-arthrosis, Ann.
Rheum. Dis. 16 (1957) 494–502.
[59] K. Barker, S.E. Lamb, F. Toye, S. Jackson, S. Barrington, Association between
radiographic joint space narrowing, function, pain and muscle power in
severe osteoarthritis of the knee, Clin. Rehabil. 18 (2004) 793–800.
[60] N.A. Segal, J.C. Torner, D.T. Felson, J. Niu, L. Sharma, C.E. Lewis, M. Nevitt, Knee
extensor strength does not protect against incident knee symptoms at 30
months in the multicenter knee osteoarthritis (MOST) cohort, PM R 1 (2009)
459–465.
[61] M.C. Hall, S.P. Mockett, M. Doherty, Relative impact of radiographic osteoar-
thritis and pain on quadriceps strength, proprioception, static postural sway
and lower limb function, Ann. Rheum. Dis. 65 (2006) 865–870.
[62] P. Creamer, M. Lethbridge-Cejku, M.C. Hochberg, Factors associated with
functional impairment in symptomatic knee osteoarthritis, Rheumatology
(Oxford) 39 (2000) 490–496.
[63] T.E. McAlindon, C. Cooper, J.R. Kirwan, P.A. Dieppe, Determinants of disability
in osteoarthritis of the knee, Ann. Rheum. Dis. 52 (1993) 258–262.
[64] M.P. Steultjens, J. Dekker, M.E. van Baar, R.A. Oostendorp, J.W. Bijlsma, Muscle
strength, pain and disability in patients with osteoarthritis, Clin. Rehabil. 15
(2001) 331–341.
[65] O. Bruyere, A. Honore, L.C. Rovati, G. Giacovelli, Y.E. Henrotin, L. Seidel,
J.Y. Reginster, Radiologic features poorly predict clinical outcomes in knee
osteoarthritis, Scand. J. Rheumatol. 31 (2002) 13–16.
[66] E.L. Radin, R.M. Rose, Role of subchondral bone in the initiation and progres-
sion of cartilage damage, Clin. Orthop. Relat. Res. (1986) 34–40.
[67] B.W. Penninx, H. Abbas, W. Ambrosius, B.J. Nicklas, C. Davis, S.P. Messier,
M. Pahor, Inﬂammatory markers and physical function among older adults
with knee osteoarthritis, J. Rheumatol. 31 (2004) 2027–2031.
[68] M. Visser, M. Pahor, D.R. Taaffe, B.H. Goodpaster, E.M. Simonsick, A.
B. Newman, M. Nevitt, T.B. Harris, Relationship of interleukin-6 and tumor
necrosis factor-alpha with muscle mass and muscle strength in elderly men
and women: the Health ABC Study, J. Gerontol. A Biol. Sci. Med. Sci. 57 (2002)
M326–M332.
[69] L.A. Schaap, S.M. Pluijm, D.J. Deeg, M. Visser, Inﬂammatory markers and loss of
muscle mass (sarcopenia) and strength, Am. J. Med. 119 (2006) (e9–e17).
[70] M. Cesari, B.W. Penninx, M. Pahor, F. Lauretani, A.M. Corsi, W.G. Rhys,
J.M. Guralnik, L. Ferrucci, Inﬂammatory markers and physical performance
in older persons: the InCHIANTI study, J. Gerontol. A Biol. Sci. Med. Sci. 59
(2004) 242–248.
[71] O.P. Stannus, G. Jones, L. Blizzard, F.M. Cicuttini, C. Ding, Associations between
serum levels of inﬂammatory markers and change in knee pain over 5 years in
older adults: a prospective cohort study, Ann. Rheum. Dis. 72 (2013) 535–540.
[72] P.J. McLaughlin, J.L. Weihrauch, Vitamin E content of foods, J. Am. Diet Assoc.
75 (1979) 647–665.
[73] J. Lehmann, H.L. Martin, E.L. Lashley, M.W. Marshall, J.T. Judd, Vitamin E in
foods from high and low linoleic acid diets, J. Am. Diet Assoc. 86 (1986)
1208–1216.
[74] T. Barker, Vitamin E and inﬂammation, in: M.L. Garg, L.G. Wood (Eds.),
Nutrition & Physical Activity in Inﬂammatory Diseases, CABI, Boston, 2013,
pp. 87–98.
[75] Q. Jiang, Ames B.N. Gamma-tocopherol, but not alpha-tocopherol, decreases
proinﬂammatory eicosanoids and inﬂammation damage in rats, J. Federation
Am. Soc. Exp. Biol. 17 (2003) 816–822.
[76] Q. Jiang, I. Elson-Schwab, C. Courtemanche, B.N. Ames, gamma-tocopherol and
its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase
activity in macrophages and epithelial cells, Proc. Natl. Acad. Sci. U. S. A. 97
(2000) 11494–11499.
[77] Z. Jiang, X. Yin, Q. Jiang, Natural forms of vitamin E and 130-carboxychromanol,
a long-chain vitamin E metabolite, inhibit leukotriene generation from
stimulated neutrophils by blocking calcium inﬂux and suppressing 5-
lipoxygenase activity, respectively, J. Immunol. 186 (2011) 1173–1179.
[78] L.A. Joosten, M.M. Helsen, F.A. van de Loo, W.B. van den Berg, Anticytokine
treatment of established type II collagen-induced arthritis in DBA/1 mice. A
comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra,
Arthritis Rheum. 39 (1996) 797–809.
[79] C. Ruggiero, A. Cherubini, J. Guralnik, R.D. Semba, M. Maggio, S.M. Ling,
F. Lauretani, S. Bandinelli, U. Senin, L. Ferrucci, The interplay between uric acid
and antioxidants in relation to physical function in older persons, J. Am.
Geriatr. Soc. 55 (2007) 1206–1215.
[80] N. Dalbeth, A. Horne, G.D. Gamble, R. Ames, B. Mason, F.M. McQueen, M.
J. Bolland, A. Grey, I.R. Reid, The effect of calcium supplementation on serum
urate: analysis of a randomized controlled trial, Rheumatology (Oxford) 48
(2009) 195–197.
[81] J.Y. Hui, J.W. Choi, D.B. Mount, Y. Zhu, Y. Zhang, H.K. Choi, The independent
association between parathyroid hormone levels and hyperuricemia: a
national population study, Arthritis Res. Ther. 14 (2012) R56.
[82] M.C. Chapuy, P. Preziosi, M. Maamer, S. Arnaud, P. Galan, S. Hercberg,
P.J. Meunier, Prevalence of vitamin D insufﬁciency in an adult normal
population, Osteoporos. Int. 7 (1997) 439–443.
T. Barker et al. / Redox Biology 2 (2014) 466–474474
